GlassScriptPhysician profile
Hai X Le
NPI 1083804801
$3,376.86
in general payments reported to CMS, 2019-2025
12 companies · $347 in 2025
The $347 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $453 · 2020: $125 · 2021: $833 · 2022: $438 · 2023: $380 · 2024: $801 · 2025: $347.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,528.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,527.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $1,093.89 | 2022-2025 | Tecvayli, Darzalex, Talvey |
| Janssen Pharmaceuticals, INC | $995.44 | 2019-2022 | |
| Pfizer INC. | $231.96 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $204.12 | 2021-2022 | |
| Abbott Laboratories | $125.31 | 2025 | Thoratec Heartmate 3 Lvas Implant Kit |
| Gilead Sciences, INC. | $125.00 | 2020 | |
| Phathom Pharmaceuticals, INC. | $124.56 | 2024 | Voquezna |
| Novartis Pharmaceuticals Corporation | $123.04 | 2019 | |
| Amgen INC. | $120.06 | 2023 | Repatha |
| Redhill Biopharma INC. | $93.98 | 2025 | Talicia |
| Inari Medical, INC. | $92.78 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Nuvasive, INC. | $46.72 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hai Le listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.